Artia Global Partners’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,000	Closed	-$1.16M	–	43
2024 Q3	$1.16M	Hold	20,000	–	–	0.32%	30
2024 Q2	$914K	Buy	+20,000	New	+$914K	0.18%	34